In the News

Recent Coverage of HMS in the News
September 27, 2012

Radiation therapy and chemotherapy aimed at killing cancer cells may have the undesirable effect of helping to create cancer stem cells, which are thought to be particularly adept at generating new tumors and are especially resistant to treatment, researchers say. Chiang Li, HMS lecturer on medicine at Beth Israel Deaconess Medical Center, is the lead author of the study.

September 26, 2012

Vanessa Kerry, HMS instructor in medicine at Massachusetts General Hospital, has created a partnership with the Peace Corps to send doctors and nurses abroad. In return a non-profit pays off part of school loans.

September 26, 2012

A cellular signature seen in the blood of multiple sclerosis patients may help determine their likelihood of relapse, potentially influencing which therapy physicians prescribe, a study found. Philip De Jager, HMS associate professor of neurology at Brigham and Women’s Hospital, is an author of the study.

September 26, 2012

Thanks to the recent findings of a team of Harvard researchers, scientists can now view more than four microspecies at once using fluorescent microscopy—a development which will give scientists a fuller understanding of the samples they are examining. Peng Yin, HMS assistant professor of systems biology; William Shih, HMS associate professor of biological chemistry and molecular pharmacology at Dana-Farber Cancer Institute; and George Church, Robert Winthrop Professor of Genetics at HMS, led the team.

September 26, 2012

As sugar-packed sodas gain a deservedly bad reputation for packing pounds on kids, sports drinks are emerging as a “healthier” alternative -- but for most kids they’re just empty calories in disguise, a new study says.  Yet they often turn up in school vending machines --and use is rising especially in boys. Alison Field, HMS associate professor of pediatrics at Boston Children’s Hospital, led the study.

September 25, 2012

A team from Boston Children’s Hospital is tracking reported cases abroad of a new virus identified this week as being from the same family of viruses that cause common colds and serious acute respiratory syndrome, the infection better known as SARS that killed hundreds around the world in a 2003 outbreak. John Brownstein, HMS associate professor of pediatrics at Boston Children’s Hospital, is the founder of the technology that tracks the disease.

September 25, 2012

A trial of a repurposed experimental cancer drug has given parents, physicians, and scientists their first tantalizing evidence that it is possible to affect the course of a rare, fatal disease that causes children to age prematurely and die before reaching adulthood. Mark Kieran, HMS associate professor of pediatrics at Boston Children’s Hospital, led the trial. Leslie Gordon, HMS lecturer on anaesthesia at Boston Children’s Hospital, is also quoted.

September 25, 2012

A class of drugs commonly given to children undergoing tonsillectomy is not likely to increase the risk of serious bleeding after surgery, according to a new U.S. study. Christopher Hartnick, HMS professor of otology and laryngology at Massachusetts Eye and Ear Infirmary, is a co-author of the study.

Pages

Submit Photo Requests to HMS
To request photos from the HMS Office of Communications and External Relations, click here.

 

Tell us about your awards
Share news of your achievements with the larger HMS community.  Click here.

 

Book Reviews
If you are a faculty member who has published a book recently, click here.